EP2583978

Prevention and treatment of synucleinopathic and amyloidogenic disease

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    22.2.2008
  • EP published:
    6.4.2016
  • EP application number:
    12188562.8
  • Max expiry date:
    21.2.2028
  • Title:
    Prevention and treatment of synucleinopathic and amyloidogenic disease

Timeline

Today
22.2.2008EP application
6.4.2016EP Publication

Owner

  • Name:
    Prothena Biosciences Limited
  • Address:
    Adelphi Plaza Upper George's Street Dun Laoghaire, Co. Dublin, IE
  • Name:
    The Regents of the University of California
  • Address:
    1111 Franklin Street, 12th Floor, 94607, Oakland, CA, US

Inventor

  • Name:
    Schenk, Dale B.
  • Address:
    Burlingame, CA , US
  • Name:
    Masliah, Eliezer
  • Address:
    San Diego, AZ , US
  • Name:
    Buttini, Manuel, J.
  • Address:
    Emeryville, CA, US
  • Name:
    Chilcote, Tamie, J.
  • Address:
    San Francisco, CA, US
  • Name:
    Rockenstein, Edward
  • Address:
    Chula Vista, CA , US
  • Name:
    Games, Kate, Dora
  • Address:
    Belmont, CA , US

Priority

  • Number:
    710248
  • Date:
    23.2.2007
  • Country:
    US
  • Number:
    697646
  • Date:
    6.4.2007
  • Country:
    US
  • Number:
    984721 P
  • Date:
    1.11.2007
  • Country:
    US

Classification

  • Categories:
    C07K 16/18, C07K 16/28, A61K 39/00

Upload documents